Superagonist, Full Agonist, Partial Agonist, and Antagonist Actions of Arylguanidines at 5-Hydroxytryptamine-3 (5-HT3) Subunit A Receptors. 2016

Katie Alix, and Shailesh Khatri, and Philip D Mosier, and Samantha Casterlow, and Dong Yan, and Heather L Nyce, and Michael M White, and Marvin K Schulte, and Małgorzata Dukat
Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University , Richmond, Virginia 23298, United States.

Introduction of minor variations to the substitution pattern of arylguanidine 5-hydroxytryptamine-3 (5-HT3) receptor ligands resulted in a broad spectrum of functionally-active ligands from antagonist to superagonist. For example, (i) introduction of an additional Cl-substituent(s) to our lead full agonist N-(3-chlorophenyl)guanidine (mCPG, 2; efficacy % = 106) yielded superagonists 7-9 (efficacy % = 186, 139, and 129, respectively), (ii) a positional isomer of 2, p-Cl analog 11, displayed partial agonist actions (efficacy % = 12), and (iii) replacing the halogen atom at the meta or para position with an electron donating OCH3 group or a stronger electron withdrawing (i.e., CF3) group resulted in antagonists 13-16. We posit based on combined mutagenesis, crystallographic, and computational analyses that for the 5-HT3 receptor, the arylguanidines that are better able to simultaneously engage the primary and complementary subunits, thus keeping them in close proximity, have greater agonist character while those that are deficient in this ability are antagonists.

UI MeSH Term Description Entries
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014981 Xenopus An aquatic genus of the family, Pipidae, occurring in Africa and distinguished by having black horny claws on three inner hind toes.

Related Publications

Katie Alix, and Shailesh Khatri, and Philip D Mosier, and Samantha Casterlow, and Dong Yan, and Heather L Nyce, and Michael M White, and Marvin K Schulte, and Małgorzata Dukat
March 1997, European journal of pharmacology,
Katie Alix, and Shailesh Khatri, and Philip D Mosier, and Samantha Casterlow, and Dong Yan, and Heather L Nyce, and Michael M White, and Marvin K Schulte, and Małgorzata Dukat
August 2015, British journal of pharmacology,
Katie Alix, and Shailesh Khatri, and Philip D Mosier, and Samantha Casterlow, and Dong Yan, and Heather L Nyce, and Michael M White, and Marvin K Schulte, and Małgorzata Dukat
January 2023, PloS one,
Katie Alix, and Shailesh Khatri, and Philip D Mosier, and Samantha Casterlow, and Dong Yan, and Heather L Nyce, and Michael M White, and Marvin K Schulte, and Małgorzata Dukat
January 1998, Neuropharmacology,
Katie Alix, and Shailesh Khatri, and Philip D Mosier, and Samantha Casterlow, and Dong Yan, and Heather L Nyce, and Michael M White, and Marvin K Schulte, and Małgorzata Dukat
January 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Katie Alix, and Shailesh Khatri, and Philip D Mosier, and Samantha Casterlow, and Dong Yan, and Heather L Nyce, and Michael M White, and Marvin K Schulte, and Małgorzata Dukat
May 1998, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Katie Alix, and Shailesh Khatri, and Philip D Mosier, and Samantha Casterlow, and Dong Yan, and Heather L Nyce, and Michael M White, and Marvin K Schulte, and Małgorzata Dukat
February 1993, British journal of pharmacology,
Katie Alix, and Shailesh Khatri, and Philip D Mosier, and Samantha Casterlow, and Dong Yan, and Heather L Nyce, and Michael M White, and Marvin K Schulte, and Małgorzata Dukat
January 2019, Biochemical and biophysical research communications,
Katie Alix, and Shailesh Khatri, and Philip D Mosier, and Samantha Casterlow, and Dong Yan, and Heather L Nyce, and Michael M White, and Marvin K Schulte, and Małgorzata Dukat
April 2005, Neurogastroenterology and motility,
Katie Alix, and Shailesh Khatri, and Philip D Mosier, and Samantha Casterlow, and Dong Yan, and Heather L Nyce, and Michael M White, and Marvin K Schulte, and Małgorzata Dukat
October 1994, Molecular pharmacology,
Copied contents to your clipboard!